Avian influenza (WHO)
World Health Organization (WHO) situation updates for Avian influenza. WHO is the directing and coordinating authority for health within the United Nations system. It is responsible for providing leadership on global health matters, shaping the health research agenda, setting norms and standards, articulating evidence-based policy options, providing technical support to countries and monitoring and assessing health trends.
-
A Study to Evaluate the Safety and Immune Response of mRNA-1345, a Vaccine Targeting Respiratory Syncytial Virus (RSV), When Co-administered With a Fluzone HD, in Adults ≥65 Years of Age
Sep 29, 2023 | 06:00 amConditions: Respiratory Syncytial Virus Interventions: Biological: Placebo; Biological: mRNA-1345; Biological: Fluzone HD Sponsors: ModernaTX, Inc. Not yet recruiting
-
Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2023/24
Sep 28, 2023 | 06:00 amConditions: Influenza Immunization (Healthy Volunteers) Interventions: Biological: Quadrivalent Influenza Vaccine; Biological: High-Dose Quadrivalent Influenza Vaccine Sponsors: Sanofi Not yet recruiting
-
Behavioral Economics to Improve Flu Vaccination Using EHR Nudges
Sep 28, 2023 | 06:00 amConditions: Behavior, Health; Flu; Flu Vaccination Interventions: Behavioral: Pre-visit patient text messaging; Behavioral: Default pended order; Behavioral: Monthly peer comparison feedback; Behavioral: High risk bidirectional pre-visit text messaging Sponsors: University of Pennsylvania; National Institute on Aging (NIA); University of Washington Not yet recruiting
-
Randomized Controlled Trial to Evaluate the Immunogenicity of an Adjuvanted Influenza Vaccine Among HCP
Sep 26, 2023 | 06:00 amConditions: Influenza Interventions: Biological: FLUAD Quadrivalent; Biological: FluQuadri Sponsors: Centers for Disease Control and Prevention; Naval Medical Research Unit- 6; Peruvian Clinical Research; Hospital Nacional Cayetano Heredia; Hospital Nacional Arzobispo Loayza Active, not recruiting
-
A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy
Sep 26, 2023 | 06:00 amConditions: Neuroendocrine Tumor (NET); Colorectal Cancer (CRC) Interventions: Biological: CHM-2101 CAR-T cells; Biological: CHM-2101 CAR-T cells Sponsors: Chimeric Therapeutics Not yet recruiting
-
Pilot Clinical Investigation to Evaluate a Prototype of Sensor Measuring Ventilator-derived Parameters
Sep 26, 2023 | 06:00 amConditions: Mechanically Ventilated Patients Interventions: Device: prototype of sensor Sponsors: Archeon Not yet recruiting
-
A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergic Rhinitis
Sep 25, 2023 | 06:00 amConditions: Allergic Rhinitis Interventions: Drug: azelastine/fluticasone 137/50 mcg nasal spray; Drug: Dymista™ Sponsors: Synmosa Biopharma Corp. Completed
-
Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) and Influenza Treatment System With Machine Learning
Sep 25, 2023 | 06:00 amConditions: COVID-19; Post-COVID-19 Syndrome; Influenza Interventions: Other: Autonomous Treatment System for Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection and Influenza Based on Machine Learning Sponsors: Lizora LLC; Sheng'ai Traditional Chinese Medicine Hospital Enrolling by invitation
-
A Phase III Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months
Sep 22, 2023 | 06:00 amConditions: Seasonal Influenza Interventions: Biological: Quadrivalent influenza vaccine(0.25ml); Biological: Quadrivalent influenza vaccine(0.5ml); Biological: Trivalent influenza vaccine(BV); Biological: Trivalent influenza vaccine(BY) Sponsors: Sinovac Biotech Co., Ltd Not yet recruiting
-
Studying Respiratory Infections and Colonisation in Children Using Daily Minimally-invasive Nasal Sampling
Sep 22, 2023 | 06:00 amConditions: Respiratory Tract; Infection, Upper (Acute); Colonization, Asymptomatic Sponsors: Leiden University Medical Center; Spaarne Gasthuis Recruiting
-
H7HLAII DNA Influenza Vaccine
Sep 21, 2023 | 06:00 amConditions: Influenza A; Pandemic Influenza Interventions: Biological: H7HLAII Sponsors: Oslo University Hospital Recruiting
-
Effect of Health Education on Promoting Influenza Vaccination Health Literacy
Sep 21, 2023 | 06:00 amConditions: Vaccination; Infection; Influenza Interventions: Combination Product: Health education Sponsors: Sun Yat-sen University Recruiting
-
Agaricus Bisporus and Influenza Vaccination Response
Sep 18, 2023 | 06:00 amConditions: Immune Response Interventions: Biological: Influenza vaccine; Dietary Supplement: Agaricus bisporus capsules; Dietary Supplement: Control capsules Sponsors: Maastricht University Medical Center; Scelta Mycofriends B.V.; CNC Grondstoffen B.V. Not yet recruiting
